{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihzcc7ymkxzshr6tlgab7qwvfjq464p7jyraohljciotzqllw7ovu",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3mmh74vgsbul2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiacstxr2mqf75ksvzdwcyej5jwi3m6q4zwt4l66icw4lw3zjf3bbm"
    },
    "mimeType": "image/jpeg",
    "size": 1653
  },
  "path": "/story/389660/weight-loss-drugs-tied-to-lower-cancer-progression.html",
  "publishedAt": "2026-05-22T08:10:00.000Z",
  "site": "https://www.newser.com",
  "textContent": "Blockbuster weight-loss drugs may be doing more than shrinking waistlines—they could be slowing cancer, too. Four observational studies suggest patients on GLP-1 medications such as Ozempic and Mounjaro had slower tumor growth, were less likely to see early-stage cancers advance, and in some cases were less likely to develop...",
  "title": "This Pattern on Weight Loss Drugs Is 'Hard to Ignore'"
}